The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.30
Bid: 81.60
Ask: 81.80
Change: 0.30 (0.37%)
Spread: 0.20 (0.245%)
Open: 81.50
High: 82.60
Low: 81.20
Prev. Close: 81.00
THRL Live PriceLast checked at -
Target Healthcare REIT is an Investment Trust

To provide ordinary shareholders with an attractive level of income with the potential for capital and income growth from investing in best-in-class care home assets with attractive financial characteristics.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

13 Nov 2013 07:00

RNS Number : 8428S
Target Healthcare REIT Limited
13 November 2013
 



To: RNS

From: Target Healthcare REIT Limited

Date: 13 November 2013

Interim Management Statement

Introduction

Target Healthcare REIT Limited ("Target Healthcare" or the "Company"), a specialist investor in UK care homes, is today pleased to issue its Interim Management Statement for the period from 1 July 2013 to 30 September 2013.

 

Investment objective

The Company's investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long leasehold care homes, that are let to care home operators, and other healthcare assets in the UK.

 

Highlights

· Further care home acquired in September 2013 for £4.0m (including acquisition costs).

· Unaudited Net Asset Value ("NAV") per share as at 30 September 2013 of 94.46 pence.

· Second interim dividend declared of 1.5 pence per share for the period to 30 September 2013.

 

Performance summary

 

Capital Values

As at 30

June 2013

As at 30 September 2013

 

Movement

Net asset value per share (pence) *

96.00

94.46

(1.54)

Ordinary share price (pence)

106.25

105.50

(0.75)

Premium to net asset value

10.7%

11.7%

 

* Calculated under International Financial Reporting Standards.

(Sources: R&H Fund Services Limited and Bloomberg)

 

Period commentary

The Company's NAV at 30 September 2013 was 94.46 pence per share and the share price was 105.5p. The NAV per share decreased by 1.54 pence during the period from 30 June 2013 to 30 September 2013 principally as a consequence of the dividend paid to shareholders of 2.0 pence on 30 August 2013.

The Company has a strong level of liquidity and had a positive cash balance at 30 September 2013 of £12.4m.

Property acquisitions

During September 2013 the Company acquired the freehold of a new care home for approximately £4.0m, including acquisition costs. Located in Thirsk, North Yorkshire, the care home is a modern, purpose-built home completed in 2013 and is leased to existing operator Ideal Carehomes Group.

The Company is pleased to report that the aggregate net initial rental yield on acquisition across the portfolio remains ahead of the 7% blended initial yield modelled pre-launch. The rents payable are subject to annual uplifts in line with the retail prices index subject to a cap and collar.

 

Geographical analysis

Location

% of Portfolio

As at 30 September 2013

Scotland

39.5%

East Midlands

37.5%

Yorkshire & Humberside

23.0%

 

Dividends

The Company paid its first interim dividend for the period from launch to 30 June 2013 of 2.0 pence per share on 30 August 2013.

 

Outlook

During the period to the end of September 2013, the healthcare property sector continued to attract interest from domestic and international investors.

The supply of quality stock being openly marketed across the sector remains limited; however, with the Company's demonstrable success in identifying and sourcing a range of attractive investment opportunities, both on- and off-market, the outlook for the sector and Target Healthcare remains positive.

In this regard, the Company's investment adviser maintains a good pipeline of additional acquisition opportunities.

The Company continues to engage in positive discussions with a number of UK financial institutions with regards to the raising of a modest level of debt funding to supplement the equity it has raised.

 

Subsequent events

During October 2013 the Company acquired a further two care homes in the North West of England for approximately £11.5m (including acquisition costs). Located in Longridge, near Preston, Lancashire and St Helens, Merseyside, both properties are modern, purpose-built homes.

The care homes will continue to be leased to existing operator Orchard Care Homes for a period of approximately 30 years and the transaction represents an initial yield in excess of 7%. These acquisitions increase the Company's property portfolio to ten care homes and Orchard Care Homes represents the third tenant in the portfolio.

Upon completion of these acquisitions the Company was fully invested. On 9 October 2013 Target Healthcare published a prospectus in connection with a placing and offer for subscription of up to 45 million ordinary shares of no par value at an issue price of 101 pence per ordinary share. On 25 October 2013, the Company announced that the issue was over-subscribed and gross proceeds of approximately £45.5m had been raised.

Following the admission of the ordinary shares to trading on the main market of the London Stock Exchange and to the Official List of the UK Listing Authority, the admission became effective and dealings in the ordinary shares commenced on 28 October 2013.

On 17 October 2013, the Company declared its second interim dividend payment of 1.50 pence per share in respect of the period from 1 July 2013 to 30 September 2013. This will be paid to shareholders on 29 November 2013.

Additionally, the Company declared its third interim dividend payment in respect of the period from 1 October 2013 to 27 October of 0.44 pence per share. It is anticipated that, in the absence of unforeseen circumstances, the Company will pay a further interim dividend of 1.06 pence per share on the same day as the third interim dividend (28 February 2014) for the remainder of the quarter to 31 December 2013.

 

Enquiries

Kenneth MacKenzie

Target Advisers LLP

01786 406 581

Martin Cassels

R&H Fund Services Limited

0131 524 6140

Graeme Caton

Winterflood Securities

020 3100 0268

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSELLFFXFFLFBZ
Date   Source Headline
9th May 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSHalf-year Report
8th Mar 20249:00 amRNSInvestor Presentation via Investor Meet Company
22nd Feb 20247:00 amRNSNotice of Half Year Results
6th Feb 20242:00 pmEQSEdison issues update on Target Healthcare REIT (THRL): Rent cover at a high and fully covered DPS
1st Feb 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
30th Nov 20237:00 amRNSResult of AGM
7th Nov 202310:16 amEQSEdison issues outlook on Target Healthcare REIT (THRL): DPS growth from a sustainable base
1st Nov 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
31st Oct 20235:30 pmRNSAnnual Financial Report
10th Oct 20237:00 amRNSFinal Results
4th Oct 20232:00 pmRNSNotice of Full Year Results
11th Aug 20238:09 amRNSEdison issues update on Target Healthcare REIT
2nd Aug 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd May 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Mar 202311:37 amRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSHalf-year Report
27th Mar 20237:00 amRNSDisposal of four care homes in Northern Ireland
23rd Mar 20237:00 amRNSNotice of Half Year Results
17th Feb 202311:08 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSNet Asset Value, Corporate Update & Dividend
7th Dec 20227:00 amRNSDirectorate Change
6th Dec 20222:30 pmRNSResult of AGM
21st Nov 20225:07 pmRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSHolding(s) in Company
8th Nov 20225:47 pmRNSAnnual Financial Report
2nd Nov 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Oct 20229:17 amRNSHolding(s) in Company
17th Oct 20229:20 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSFinal Results
12th Oct 20227:00 amRNSDirectorate Change
1st Sep 20227:00 amRNSPortfolio Update
4th Aug 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
22nd Jun 20227:00 amRNSHolding(s) in Company
9th Jun 20226:01 pmRNSHolding(s) in Company
9th Jun 20227:00 amRNSInclusion in FTSE 250 Index
6th Jun 20229:42 amRNSHolding(s) in Company
9th May 202211:43 amRNSDirector/PDMR Shareholding
5th May 202210:01 amRNSHolding(s) in Company
5th May 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd May 20229:21 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSHalf-year Report
10th Mar 20227:00 amRNSNotice of Half Year Results
1st Feb 20227:00 amRNSDirectorate Change
27th Jan 20227:00 amRNSNet Asset Value, Corporate Update & Dividend
20th Dec 20217:00 amRNSCompletion of Portfolio Acquisition
15th Dec 20217:00 amRNSResult of AGM
30th Nov 20217:00 amRNSNew long-term institutional debt facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.